Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

49.27 +0.38 (+0.77%)
Streaming Delayed Price Updated: 12:25 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
39 40 Next >
News headline image
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis ↗
 
Via Benzinga
News headline image
Sanofi's Fitusiran Prophylaxis Cuts Bleeds By 61% In Hemophilia Patients ↗
 
Via Benzinga
News headline image
Biotech Stocks To Watch And Pharma Industry News ↗
Track the latest trends and leading stocks in the biotech and pharmaceutical industries. 
Via Investor's Business Daily
News headline image
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market ↗
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and... 
Via Benzinga
News headline image
Sanofi Dives After FDA Slaps Its $3.7 Billion Drug With A Hold ↗
The company was testing the drug in multiple sclerosis and myasthenia gravis. 
Via Investor's Business Daily
News headline image
Why Sanofi Shares Are Falling Today ↗
 
Via Benzinga
News headline image
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Sanofi with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Sanofi with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
How Is The Market Feeling About Sanofi? ↗
Sanofi's (NASDAQ:SNY) short percent of float has fallen 22.22% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 0.14% of... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates ↗
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline' ↗
The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news,... 
Via Benzinga
News headline image
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients ↗
 
Via Benzinga
News headline image
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes ↗
The companies' shot was more than 93% effective in previously infected people. 
Via Investor's Business Daily
News headline image
Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24 ↗
Reuters 
Via Benzinga
News headline image
Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron ↗
 
Via Benzinga
News headline image
This Pharmaceutical Company Is Moving Beyond CBD ↗
The applications for cannabidiol (CBD) and cannabinoid-based therapeutics are many. Many novel treatments have been, and are continuing to be, discovered using these compounds. The industry is huge... 
Via Benzinga
News headline image
Jupiter Wellness Believes Its Latest Strategic Acquisition Could Be A Significant Boon To Compete In The Medical Cannabis Industry ↗
Companies like Tilray Inc. (NASDAQ: TLRY) and Cara Therapeutics Inc. 
Via Benzinga
News headline image
Clovis Oncology (CLVS) Stock Gains 20% on Tumor Trials, Buyout Hopes ↗
Today has been another strong one for investors in Clovis Oncology and CLVS stock, with this company surging another 20% in today's session. 
Via InvestorPlace
News headline image
Clovis Oncology (CLVS) Stock Rallies on Buyout Rumors ↗
Pharmaceutical startup CLVS stock is climbing 25% higher today on rumors that the cancer drug maker has become a takeover target. 
Via InvestorPlace
News headline image
Morning Brief: Top Financial Stories Dominating on Monday, June 13 ↗
CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why 
Via Benzinga
News headline image
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern ↗
 
Via Benzinga
News headline image
We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit ↗
The conversation around obesity is changing. Two diabetes drug makers are at the forefront. 
Via Investor's Business Daily
Pfizer’s CDI Trial Miss Puts Acurx Pharmaceuticals Ibezapolstat In Front-Line Position, Here’s Why Big Pharma May Come Calling ($ACXP)
Via AB Newswire
News headline image
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
U.S. FDA Approves Regeneron And Sanofi's Lead Drug For Skin Inflammation In Children ↗
The U.S. 
Via Benzinga
News headline image
CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment ↗
Key Takeaways: CStone brought four products to market last year, and its losses have surged due to growing R&D and sales spending Appointment of chairman with close ties... 
Via Benzinga
Acurx Pharmaceuticals Is Under The Radar, That’s Excellent News For Investors Wanting Exposure To Billion Dollar CDI Treatment Market ($ACXP)
Via AB Newswire
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.